Regeneron Pharmaceuticals Inc (REGN)
890.68
-15.86
(-1.75%)
USD |
NASDAQ |
Apr 25, 16:00
889.00
-1.68
(-0.19%)
After-Hours: 20:00
Regeneron Pharmaceuticals 1 Year Total Returns (Daily): 12.80% for April 25, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 25, 2024 | 12.80% |
April 24, 2024 | 13.74% |
April 23, 2024 | 13.31% |
April 22, 2024 | 12.42% |
April 19, 2024 | 10.87% |
April 18, 2024 | 10.64% |
April 17, 2024 | 9.94% |
April 16, 2024 | 7.81% |
April 15, 2024 | 8.35% |
April 12, 2024 | 10.27% |
April 11, 2024 | 12.28% |
April 10, 2024 | 13.65% |
April 09, 2024 | 13.90% |
April 08, 2024 | 13.24% |
April 05, 2024 | 14.24% |
April 04, 2024 | 13.98% |
April 03, 2024 | 15.10% |
April 02, 2024 | 16.19% |
April 01, 2024 | 17.97% |
March 28, 2024 | 16.39% |
March 27, 2024 | 17.78% |
March 26, 2024 | 17.51% |
March 25, 2024 | 17.21% |
March 22, 2024 | 28.74% |
March 21, 2024 | 27.41% |
Date | Value |
---|---|
March 20, 2024 | 27.36% |
March 19, 2024 | 28.89% |
March 18, 2024 | 28.39% |
March 15, 2024 | 26.85% |
March 14, 2024 | 25.07% |
March 13, 2024 | 28.33% |
March 12, 2024 | 29.93% |
March 11, 2024 | 29.11% |
March 08, 2024 | 30.01% |
March 07, 2024 | 25.78% |
March 06, 2024 | 24.57% |
March 05, 2024 | 23.86% |
March 04, 2024 | 24.62% |
March 01, 2024 | 27.57% |
February 29, 2024 | 27.05% |
February 28, 2024 | 29.88% |
February 27, 2024 | 31.09% |
February 26, 2024 | 30.69% |
February 23, 2024 | 29.16% |
February 22, 2024 | 28.98% |
February 21, 2024 | 27.64% |
February 20, 2024 | 26.46% |
February 16, 2024 | 28.75% |
February 15, 2024 | 26.89% |
February 14, 2024 | 25.67% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-32.65%
Minimum
Sep 27 2019
120.8%
Maximum
Jul 20 2020
21.46%
Average
16.41%
Median
Nov 22 2022
1 Year Total Returns (Daily) Benchmarks
Vertex Pharmaceuticals Inc | 19.81% |
Eli Lilly and Co | 89.92% |
AbbVie Inc | 5.58% |
Amgen Inc | 13.71% |
Pfizer Inc | -32.41% |